Most Read Articles
Discover personalized insights and stories to improve your wellness
Need help making sense of cancer care?
Talk to a patient counselor for free guidance tailored to your situation.
Search Results
BACK TO ALL ARTICLESAll Cancer Articles
View more...
Tucatinib
Understanding Tucatinib: What It Is and How It Works Tucatinib is a novel medication that has been making waves in the medical community for its effectiveness in treating HER2-positive cancers. This targeted therapy offers new hope to patients with this specific type
Brigatinib
Understanding Brigatinib In recent years, the fight against cancer has seen some remarkable advancements in treatment options, with Brigatinib standing out as a significant development. This medication represents hope for many patients facing certain types of cancer, particularly non-small cell lung cancer (NSCLC) that harbors specific genetic alterations. Let's delve into
Duvelisib
Understanding Duvelisib: An Overview Duvelisib is a groundbreaking medication that has transformed the treatment landscape for certain types of cancer. As a targeted therapy, it works on a cellular level to inhibit the growth and spread of cancer cells. Specifically, Duvelisib is approved for the treatment of adult patients with relapsed
Copanlisib
Understanding Copanlisib: A Comprehensive Overview Copanlisib is an innovative therapy introduced in the medical field to provide new hope for patients battling cancer. It operates at the molecular level, specifically targeting and inhibiting phosphatidylinositol 3-kinase (PI3K), which plays a crucial role in the growth and survival of cancer cells. By impeding
Lumacaftor/ivacaftor
Understanding Lumacaftor/Ivacaftor Lumacaftor and ivacaftor, when combined, form a groundbreaking treatment initially approved for managing cystic fibrosis (CF) in certain patients. This medication duo works by improving the function of the CFTR protein, which is defective in individuals with CF. Lumacaftor helps in moving the CFTR protein
Larotrectinib
Introduction to Larotrectinib Larotrectinib, sold under the brand name Vitrakvi, represents a groundbreaking advance in the realm of cancer treatment. This medication is a targeted therapy, meaning it zeroes in on specific aspects of cancer cells to block their growth and spread. Unlike traditional chemotherapy treatments that can affect both healthy
Entrectinib
Understanding Entrectinib: A Comprehensive Overview Entrectinib, a groundbreaking medication, stands at the forefront of targeted cancer therapy. Its role as a tyrosine kinase inhibitor marks a significant advancement in the treatment of certain types of cancer. This detailed overview serves to elucidate the mechanism by which Entrectinib operates, the specific cancers
Erdafitinib
Understanding Erdafitinib: An Introduction Erdafitinib, a groundbreaking advancement in cancer treatment, represents hope for those diagnosed with specific types of cancer. This targeted therapy is known for its precision in attacking cancer cells while sparing healthy ones, a significant boon for patient outcomes and quality of life during treatment. What is Erdafitinib? Erdafitinib
Ivosidenib
Understanding Ivosidenib and Its Mechanism of Action Ivosidenib, a revolutionary advancement in the realm of cancer treatment, stands as a testament to the power of targeted therapy. Its role as an IDH1 inhibitor brings new hope to patients with specific types of cancer,
Follow us
Join the conversation on cancer care.
Personalized support for treatment decisions, side effects, and recovery.
Expert-reviewed Cancer Care Resources
At ZenOnco.io, we're dedicated to supporting cancer patients, caregivers, and survivors with thoroughly researched and trustworthy information. Our cancer care blogs are comprehensively reviewed by our team of medical writers and experts having distinguished experience in cancer care. We prioritize evidence-based content to provide you with accurate, reliable content that illuminates your healing journey, offering peace of mind and a supportive hand to hold every step of the way.
Follow us
Join the conversation on cancer care.
